Citadel Advisors - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is and the CUSIP is 036642956. A total of 1 filers reported holding ANTARES PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q2 2016$15,000
+66.7%
14,500
+101.4%
0.00%
Q4 2015$9,000
-35.7%
7,200
-11.1%
0.00%
Q3 2015$14,000
-33.3%
8,100
-21.4%
0.00%
Q2 2015$21,000
-4.5%
10,300
+25.6%
0.00%
Q1 2015$22,000
+266.7%
8,200
+272.7%
0.00%
Q4 2014$6,000
-60.0%
2,200
-72.8%
0.00%
Q3 2014$15,000
+200.0%
8,100
+376.5%
0.00%
Q2 2014$5,000
-80.8%
1,700
-76.7%
0.00%
Q1 2014$26,000
+62.5%
7,300
+108.6%
0.00%
Q4 2013$16,000
-68.0%
3,500
-71.8%
0.00%
Q3 2013$50,000
-53.7%
12,400
-52.3%
0.00%
Q2 2013$108,00026,0000.00%
Other shareholders

There were no reported owners of ANTARES PHARMA INC in Q3 2014.

NameSharesValueWeighting ↓
View complete list of ANTARES PHARMA INC shareholders